Altered expression of vascular endothelial growth factor and its receptors in normal saphenous vein and in arterialized and stenotic vein grafts

American Journal of Surgery

Volumn 186, Issue 5, 2003, Pages 561-568

  Woodside, Kenneth J ^a   Naoum, Joseph J ^a   Torry, Ronald J ^b   Xue, Xiang Y ^a   Burke, Ann S ^c   Levine, Lyuba ^a   Daller, John A ^a   Hunter, Glenn C ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b DRAKE UNIVERSITY   (United States)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Flt 1; KDR; Neuropilin 1; Stenosis; Vascular endothelial growth factor; Vein graft arterialization

Indexed keywords

NEUROPILIN 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; ADVENTITIA; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; STENOSIS; VASCULAR ENDOTHELIUM; VEIN GRAFT;

EID: 0242329859     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2003.07.023     Document Type: Article

References (40)

1. Mills J.L. The impact of duplex surveillance on infrainguinal vein bypass surgery. Adv Vasc Surg. 4:1996;201-210.
2. Laundry G.J., Moneta G.L., Taylor L.M., et al. Long-term outcome of revised lower-extremity bypass grafts. J Vasc Surg. 35:2002;56-62.
3. Idu M.M., Buth J., Hop W.C.J., et al. Factors influencing the development of vein-graft stenosis and their significance for clinical management. Eur J Vasc Endovasc Surg. 17:1999;15-21.
4. Ihnat D.M., Mills J.L., Dawson D.L., et al. The correlation of early flow disturbances with the development of infrainguinal graft stenosis a 10-year study of 341 autogenous vein grafts . J Vasc Surg. 30:1999;8-15.
5. Gahtan V., Payne L.P., Roper L.D., et al. Duplex criteria for predicting progression of vein graft lesions which stenosis can be followed? J Vasc Technol. 19:1995;211-215.
6. Mills J.L. Mechanisms of vein graft failure the location, distribution and characteristics of lesion that predispose to graft failure . Semin Vasc Surg. 6:1993;78-91.
7. Szyilagi D.E., Elliot J.P., Hageman J.H., et al. Biologic fate of autogenous vein implants as arterial substitutes clinical, angiographic and histopathologic observations in femoropopliteal operations for atherosclerosis . Ann Surg. 178:1973;232-246.
8. Westerband A., Gentile A.T., Hunter G.C., et al. Intimal growth and neovascularization in human stenotic vein grafts. J Am Coll Surg. 191:2000;264-271.
9. Westerband A., Crouse D., Richter L.C., et al. Vein adaptation to arterialization in an experimental model. J Vasc Surg. 33:2001;561-569.
10. Buth J., Disselhoff B., Sommeling C., Stam L. Color-flow duplex criteria for grading stenosis in infrainguinal vein grafts. J Vasc Surg. 14:1991;716-726.
11. Shoenfeld N.A., O'Donnell T.F., Bush H.L., et al. The management of early in situ saphenous vein bypass occlusions. Arch Surg. 122:1987;871-875.
12. Gundry S.R., Jones M., Ishihara T., Ferrans V.J. Intraoperative trauma to human saphenous veins scanning electron microscopic comparison of preparation techniques . Ann Thorac Surg. 30:1980;40-47.
13. Bush H.L., McCabe M.E., Nabseth D.C. Functional injury of vein graft endothelium role of hypothermia and distension . Arch Surg. 119:1984;770-774.
14. Stept L.L., Flinn W.R., McCarthy W.J., et al. Technical defects as a cause of early graft failure after femorodistal bypass. Arch Surg. 122:1987;599-604.
15. Brody W.R., Kosek J.G., Angel W.W. Changes in vein grafts following aortocoronary bypass induced by pressure and ischemia. J Thorac Cardiovasc Surg. 64:1972;847-854.
16. Kalra M., Miller V.M. Early remodeling of saphenous vein grafts proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow . J Vasc Res. 37:2000;576-584.
17. Galea J., Armstrong J., Francis S.E., et al. Alterations in c-fos expression, cell proliferation and apoptosis in pressure distended human saphenous vein. Cardiovasc Res. 44:1999;436-448.
18. Hoff H.F., Beck G.J., Skibinski C.I., et al. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation. 77:1988;1238-1244.
19. Westerband A., Mills J.L., Marek J.M., et al. Immunocytochemical determination of cell type and proliferation rate in human vein graft stenosis. J Vasc Surg. 25:1997;64-73.
20. Zwolak R.M., Adams M.C., Clowes A.W. Kinetics of vein graft hyperplasia association with tangential stress . J Vasc Surg. 5:1987;126-136.
21. Ramos J.R., Berger K., Mansfield P.B., et al. Histologic fate and endothelial changes of distended and non-distended vein grafts. Ann Surg. 183:1976;205-228.
22. Huynh T., Davies M., Trovato M., et al. Alterations in wall tension and shear stress modulate tyrosine kinase signaling and wall remodeling in experimental vein grafts. J Vasc Surg. 29:1999;334-344.
23. Dobrin P.B. Mechanical factors associated with the development of intimal and medial thickening in vein grafts subjected to arterial pressure. Hypertension. 26:1995;38-43.
24. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:1999;9-22.
25. Luo Z., Asahara T., Tsurumi Y., et al. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor. J Vasc Surg. 27:1998;167-173.
26. Woodside KJ, Hu M, Burke A, et al. Morphologic characteristics of varicose veins: possible role of metalloproteinases. J Vasc Surg. 2003;38:162-9.
27. Torry R.J., Bai L., Miller S.J., et al. Increased vascular endothelial growth factor expression in human hearts with microvascular fibrin. J Mol Cell Cardiol. 33:2001;175-184.
28. Mills J.L., Fujitani R.M., Taylor S.M. The characteristics and anatomic distribution of lesions that cause reversed vein graft failure a five-year prospective study . J Vasc Surg. 17:1993;195-206.
29. Bandyk D.F., Cato R.F., Towne J.B. A low flow velocity predicts failure of femoropopliteal and femorotibial bypass grafts. Surgery. 98:1985;799-807.
30. Veith F.J., Weiser R.K., Gupta S.K., et al. Diagnosis and management of failing lower extremity arterial reconstruction prior to graft occlusion. J Cardiovasc Surg. 25:1984;381-384.
31. Westerband A, Mills JL, Hunter GC, et al. Topography of cell replication in human vein graft stenoses. Circulation 1998;98:II325.
32. Sayers R.D., Watt P.A.C., Muller S., et al. Endothelial cell injury secondary to surgical preparation of reversed and in situ saphenous vein bypass grafts. Eur J Vasc Surg. 6:1992;354-361.
33. Kockx M.M., Cambier B.A., Bortier H.E., et al. Foam cell replication and smooth muscle cell apoptosis in human saphenous vein graft. Histopathology. 25:1994;365-371.
34. Shalaby F., Ho J., Stanford W.L., et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 89:1997;981-990.
35. Barleon B., Sozzani S., Zhou D., et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 87:1996;3336-3343.
36. Seetharam L., Gotoh N., Maru Y., et al. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene. 10:1995;973-984.
37. Soker S., Miao H.Q., Nomi M., et al. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J Cell Biochem. 85:2002;357-368.
38. Parenti A., Brogelli L., Filippi S., et al. Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A role of flt-1/VEGF-receptor-1 . Cardiovasc Res. 55:2002;201-212.
39. Qi J.H., Ebrahem Q., Moore N., et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3) inhibition of angiogenesis by blockade of VEGF binding to VEGF receptor-2 . Nat Med. 9:2003;407-415.
40. Gagnon M.L., Bielenberg D.R., Gechtman Z., et al. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor in vivo expression and antitumor activity . Proc Natl Acad Sci USA. 97:2000;2573-2578.